Dr. Nakaar has twenty years of experience in research and development of human vaccines in academic, small biotech and pharmaceutical environments. At VaxInnate where he joined the company at its founding in 2002, Dr. Nakaar was heavily involved in the company’s start-up. Under his leadership, the molecular biology group delivered multiple vaccine candidates including novel influenza vaccines currently undergoing clinical evaluation. He also has had extensive involvement with other viral, bacterial and parasitic vaccines. At Vion, he developed protein and peptide-based cancer therapies. He has been an author of many peer-reviewed publications, and inventor on US patents related to development and production of vaccines for influenza and other infectious diseases. Dr. Nakaar has served for nine years as a faculty member in the Department of Internal Medicine, Yale University School of Medicine.
Dr. Nakaar received his B.Sc. (Hons.) in Biological Sciences from the Kwame Nkrumah University of Science and Technology, Ghana, and his M.Sc. and Ph.D. degrees in Molecular Biology from the Weizmann Institute of Science, Israel, and carried out his postdoctoral fellowship in the Section of Infectious Diseases, Yale University School of Medicine.
Current role
Assistant Professor, Fine & Performing Arts, GITAM School of Humanities & Social Sciences, Hyderabad Campus at GITAM Deemed University
Chief Engineer, Modeling, Optimization And Data Science at ExxonMobil
SVP for Research at Penn State University
Chief Behavioral Science Officer And President Americas at Mind Gym
President & Chief Science Officer at NULASTIN
Access the worlds's biggest network of public org charts
Learn more